11-63590168-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001128203.2(PLAAT3):āc.319A>Gā(p.Lys107Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001128203.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLAAT3 | NM_001128203.2 | c.319A>G | p.Lys107Glu | missense_variant | 4/5 | ENST00000415826.3 | |
PLAAT3 | NM_007069.3 | c.319A>G | p.Lys107Glu | missense_variant | 3/4 | ||
PLAAT3 | XM_011544741.2 | c.364A>G | p.Lys122Glu | missense_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLAAT3 | ENST00000415826.3 | c.319A>G | p.Lys107Glu | missense_variant | 4/5 | 2 | NM_001128203.2 | P1 | |
PLAAT3 | ENST00000323646.9 | c.319A>G | p.Lys107Glu | missense_variant | 3/4 | 1 | P1 | ||
PLAAT3 | ENST00000394613.3 | n.413A>G | non_coding_transcript_exon_variant | 3/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251316Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135828
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461870Hom.: 0 Cov.: 33 AF XY: 0.0000193 AC XY: 14AN XY: 727226
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.319A>G (p.K107E) alteration is located in exon 3 (coding exon 3) of the PLA2G16 gene. This alteration results from a A to G substitution at nucleotide position 319, causing the lysine (K) at amino acid position 107 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at